Amicus, Biogen Sign Deal for Parkinson's Disease

September 10, 2013 | Amicus Therapeutics and Biogen Idec announced a deal today to discover, develop and commercialize small molecule drugs for Parkinson's Disease. The expenses associated with the endeavor will be borne solely by Biogen. Xconomy